1 | Cytopathology result | 422463 | Number
[1]
| 1 | Positive | 2 | Negative | 3 | Equivocal | 7 | Not applicable | 9 | Not available |
| |
2 | Lymphovascular invasion indicator | 519212 | Boolean
[1]
| | |
3 | Cervical lymphovascular invasion location | 424175 | Number
[1]
| 1 | Lymphovascular invasion present and at tumour interface | 2 | Lymphovascular invasion present and within cervix remote from tumour interface | 3 | Lymphovascular invasion present (location unknown) | 7 | Not applicable-pathology specimen not obtained or no lymphovascular invasion present | 8 | Unknown whether pathology specimen obtained | 9 | Pathology specimen obtained but lymphovascular invasion not stated/inadequately described |
| Conditional obligation: This data element is only to be recorded for patients with cervical cancer, as indicated by Person with cancer—primary site of cancer, topography code (ICD-O-3) ANN.N, and when Person with cancer—lymphovascular invasion indicator, yes/no code N indicates the presence of lymphovascular invasion. |
4 | Corpus uteri lymphovascular invasion location | 424445 | Number
[1]
| 1 | Lymphovascular invasion present and at tumour interface | 2 | Lymphovascular invasion present and within the myometrium remote to the tumour interface | 3 | Lymphovascular invasion present (location unknown) | 7 | Not applicable-pathology specimen not obtained or no lymphovascular invasion present | 8 | Unknown whether pathology specimen obtained | 9 | Pathology specimen obtained but lymphovascular invasion not stated/inadequately described |
| Conditional obligation: This data element is only to be recorded for patients with endometrial cancer, as indicated by Person with cancer—primary site of cancer, topography code (ICD-O-3) ANN.N, and when Person with cancer—lymphovascular invasion indicator, yes/no code N indicates the presence of lymphovascular invasion. |
5 | FIGO cervical cancer stage | 424190 | Number
[2]
| 1 | Stage IA1 | 2 | Stage IA2 | 3 | Stage IB1 | 4 | Stage IB2 | 5 | Stage IIA1 | 6 | Stage IIA2 | 7 | Stage IIB | 8 | Stage IIIA | 9 | Stage IIIB | 10 | Stage IVA | 11 | Stage IVB | 99 | Not available/inadequately described |
| Conditional obligation: This data element is only to be recorded for patients with cervical cancer, as indicated by Person with cancer—primary site of cancer, topography code (ICD-O-3) ANN.N. |
6 | FIGO endometrial cancer stage | 424209 | Number
[2]
| 1 | Stage IA | 2 | Stage IB | 3 | Stage II | 4 | Stage IIIA | 5 | Stage IIIB | 6 | Stage IIIC1 | 7 | Stage IIIC2 | 8 | Stage IVA | 9 | Stage IVB | 99 | Not available/inadequately described |
| Conditional obligation: This data element is only to be recorded for patients with endometrial cancer, as indicated by Person with cancer—primary site of cancer, topography code (ICD-O-3) ANN.N. |
7 | FIGO ovarian cancer stage | 424212 | Number
[2]
| 1 | Stage IA | 2 | Stage IB | 3 | Stage IC1 | 4 | Stage IC2 | 5 | Stage IC3 | 6 | Stage IIA | 7 | Stage IIB | 8 | Stage IIIA1 | 9 | Stage IIIA1(i) | 10 | Stage IIIA1(ii) | 11 | Stage IIIA2 | 12 | Stage IIIB | 13 | Stage IIIC | 14 | Stage IV | 15 | Stage IVA | 16 | Stage IVB | 99 | Not available/inadequately described |
| Conditional obligation: This data element is only to be recorded for patients with ovarian cancer, as indicated by Person with cancer—primary site of cancer, topography code (ICD-O-3) ANN.N. |
8 | Distant metastatic site indicator | 545189 | Number
[1]
| 1 | Yes | 2 | No | 9 | Not stated/inadequately described |
| |
9 | Distant metastatic site(s) at diagnosis | 424239 | Number
[2]
| 1 | Lung | 2 | Liver | 3 | Bowel | 4 | Bone | 5 | Brain | 88 | Other | 99 | Metastatic spread indicated but site not stated/inadequately described |
| Conditional obligation: This data element is to be completed if Person with cancer—distant metastatic cancer indicator, yes/no/not stated/inadequately described code N indicates the presence of metastatic cancer. |
10 | Depth of myometrial invasion | 545243 | Number
[2]
| 97 | Not applicable | 98 | Unknown | 99 | Not stated/inadequately described |
| Conditional obligation: This data element is only to be recorded for patients with endometrial cancer, as indicated by Person with cancer—primary site of cancer, topography code (ICD-O-3) ANN.N. |
11 | Myometrial thickness | 424269 | Number
[2]
| 97 | Not applicable | 98 | Unknown | 99 | Not stated/inadequately described |
| Conditional obligation: This data element is only to be recorded for patients with endometrial cancer, as indicated by Person with cancer—primary site of cancer, topography code (ICD-O-3) ANN.N. |
12 | Depth of cervical cancer invasion | 424275 | Number
[2]
| 97 | Not applicable | 98 | Unknown | 99 | Not stated/inadequately described |
| Conditional obligation: This data element is only to be recorded for patients with cervical cancer, as indicated by Person with cancer—primary site of cancer, topography code (ICD-O-3) ANN.N. |
13 | Tumour outside primary site indicator | 545382 | Number
[1]
| 1 | Yes | 2 | No | 9 | Not stated/inadequately described |
| |
14 | Tumour size outside primary site | 424282 | Number
[1]
| 1 | Macroscopic disease less than or equal to 2 cm outside the primary tumour site | 2 | Macroscopic disease between 2 cm and less than 10 cm outside primary tumour site | 3 | Macroscopic disease equal to or greater than 10 cm outside the primary tumour site | 8 | Unknown | 9 | Not stated/inadequately described |
| |
15 | Multiple primary tumours indicator | 519548 | Boolean
[1]
| | |
16 | Multiple primary tumours descriptor | 429482 | Number
[1]
| 1 | Synchronous | 2 | Metachronous | 7 | Not applicable, i.e. single primary tumour only | 8 | Number of primary tumours unknown | 9 | Multiple primary tumours present, but synchronicity not stated/inadequately described |
| Conditional obligation: This data element is to be recorded if Person with cancer—multiple primary tumours indicator, yes/no code N indicates the presence of multiple primary tumours. |
17 | Tissue sample collected indicator | 446565 | Boolean
[1]
| | |
18 | Organisation name | 453823 | String
[200]
| X[X(199)] A combination of alphanumeric characters. | Conditional obligation: This data element is to be recorded when the data element Person—tissue sample collected indicator, yes/no code N indicates that a tissue sample has been collected.DSS specific information: Use this data element to record the name of the laboratory or biobank in which a tissue sample is stored. Collect this data element in conjunction with Person—tissue sample collected indicator, yes/no code N. |
19 | Surgical specialty gynaecological cancer | 424298 | Number
[2]
| 1 | Gynaecological oncologist | 2 | Gynaecologist | 3 | General surgeon | 8 | Other | 98 | Unknown |
| Conditional obligation: This data element is only to be recorded for patients who have undergone surgery relating to their initial course of treatment for gynaecological cancer. |
20 | Tumour residual post-surgery size category | 424302 | Number
[1]
| 1 | Microscopic but no macroscopic residual disease | 2 | Residual tumour less than 0.5 cm | 3 | Residual tumour between 0.5 cm and less than 1 cm | 4 | Residual tumour between 1 cm and 2 cm | 5 | Residual tumour greater than 2 cm | 7 | Not applicable | 8 | Unknown/unable to be assessed | 9 | Not stated/inadequately described |
| Conditional obligation: This data element is to be recorded then the data element Cancer treatment—residual (R) tumour indicator, yes/no code N indicates the presence of residual tumour after surgery. |
21 | Residual tumour indicator | 430267 | Boolean
[1]
| | Conditional obligation: This data element is to be recorded for patients with ovarian cancer and stage IV endometrial cancer when surgical treatment for gynaecological cancer has been completed. |
22 | Surgical treatment complication indicator | 546455 | Number
[1]
| | |
23 | Surgical treatment complication type | 424310 | Number
[2]
| 1 | Unplanned return to theatre | 2 | Death within 30 days of surgery | 3 | Post-operative fistula | 4 | Intra-operative haemorrhage (greater than 6 units of transfusion) | 5 | Pulmonary embolism | 6 | Unplanned transfer to intensive care unit (ICU) | 7 | Post-operative stay greater than 21 days | 88 | Other complication or critical event | 98 | Unknown | 99 | Not stated/inadequately described |
| Conditional obligation: This data element is to be recorded when Cancer treatment—primary surgical treatment complication indicator, yes/no/unknown code N indicates the presence of a treatment complication. |
24 | Radiotherapy treatment complication indicator | 546597 | Number
[1]
| | Conditional obligation: This data element should be recorded in relation to the primary course of treatment for gynaecological cancer.DSS specific information: This relates to the primary course of treatment for gynaecological cancer. |
25 | Radiotherapy treatment complication type | 424314 | Number
[1]
| 1 | Bowel obstruction requiring surgery | 2 | Fistula requiring stoma formation | 3 | Pelvic insufficiency | 8 | Other | 9 | Not stated/inadequately described |
| Conditional obligation: This data element should be recorded when Cancer treatment—gynaecological cancer post-radiotherapy complication indicator, yes/no/unknown code N indicates the presence of a radiotherapy related treatment complication. |
26 | Treatment complication description | 467640 | String
[150]
| X[X(149)] A combination of alphanumeric characters. | Conditional obligation: This data element is to be recorded when either Cancer treatment—treatment complication type, gynaecological cancer-related radiotherapy code N or Cancer treatment—treatment complication type, cancer-related primary surgery complication type code N[N] indicates an 'Other' type of treatment complication. |
27 | Systemic therapy modification indicator | 546764 | Number
[1]
| | Conditional obligation: This data element is to be recorded for patients who have undergone systemic therapy as part of their cancer treatment. This includes chemotherapy, hormone therapy and immunotherapy. |
28 | Systemic therapy modification type | 424306 | String
[2]
| 01 | Dose decrease | 02 | Drug omission | 03 | Drug delivery interval increase | 04 | Dose increase | 05 | Drug introduction | 06 | Drug delivery interval decrease | 07 | Dose increase and interval decrease | 88 | Other | 99 | Not stated/inadequately described |
| Conditional obligation: This data element is to be recorded when Cancer treatment—systemic therapy treatment modification indicator, yes/no/unknown code N indicates a modification to planned systemic therapy treatment. |
29 | Treatment plan modification description | 568890 | String
[150]
| X[X(149)] A combination of alphanumeric characters. | Conditional obligation: This data element is to be recorded when Cancer treatment—treatment modification type for cancer-related systemic therapy, code N[N] indicates an 'Other' type of treatment modification. |
30 | Delay in primary course of chemotherapy indicator | 542950 | Number
[1]
| | Conditional obligation: This data element is to be recorded for patients who have undergone chemotherapy as part of their cancer treatment. |
31 | Primary course of chemotherapy delay reason | 424458 | Number
[1]
| 1 | Delay due to toxicity | 2 | Delay due to other complication | 3 | Delay due to patient decision | 8 | Other | 9 | Not stated/inadequately described |
| Conditional obligation: This data element is to be recorded when Cancer treatment—chemotherapy delay indicator, yes/no/unknown code N indicates a delay in planned chemotherapy treatment. |
32 | Cancer treatment type | 561618 | Number
[2]
| 1 | Surgery only | 2 | Radiotherapy only | 3 | Systemic agent therapy only | 4 | Surgery and radiotherapy | 5 | Surgery and systemic agent therapy | 6 | Radiotherapy and systemic agent therapy | 7 | Surgery, radiotherapy and systemic agent therapy | 97 | Not applicable—treatment was not administered | 98 | Unknown whether treatment was administered | 99 | Treatment was administered but the type was not stated/inadequately described |
| Conditional obligation: This data element is to be recorded for a patient having a first recurrence of cancer. All treatments administered to the patient during the first recurrence of cancer should be recorded.DSS specific information: This data element is to be recorded separately for the primary course of treatment and treatment for the first recurrence of cancer. All treatments administered to the patient as part of the primary course of treatment for the first recurrence of cancer should be recorded. |
33 | Other cancer treatment description | 561623 | String
[150]
| X[X(149)] The cancer-directed treatment administered to the patient that cannot be defined as surgery, radiotherapy or systemic therapy. | Conditional obligation: This data element is to be recorded for a patient having treatment that cannot be defined as surgery, radiotherapy or systemic therapy according to the definitions of those data items in this data set specification.DSS specific information: This data element is to be used to describe treatment, other than surgery, radiotherapy or systemic therapy, used to treat a first recurrence of gynaecological cancer. |
34 | Outcome of treatment | 561665 | Number
[2]
| 1.0 | Complete response/no evidence of disease | 2.1 | Partial response | 2.2 | Stable or static disease | 2.3 | Progressive disease | 7.0 | Not assessed or unable to be assessed | 8.0 | Unknown | 9.0 | Not stated/inadequately described |
| Conditional obligation: This data element is conditional on a patient completing treatment for their first recurrence of cancer.DSS specific information: This data element is to be recorded for patients who have completed their primary course of treatment or treatment for the first recurrence of cancer. For patients who have completed treatment for their first recurrence of cancer this should be recorded multiple times, once in relation to their primary course of treatment and once in relation to treatment for the first recurrence of cancer. |
35 | Cancer (clinical) DSS | 560813 |
|
| DSS specific information: The Cancer (clinical) data set specification is intended to only describe data collected in relation to the initial course of cancer treatment. The initial course of treatment includes all treatments administered to the patient from diagnosis and before disease progression or recurrence. |
- | Chemotherapy for cancer cluster | 561228 |
|
| Conditional obligation: Conditional on patient receiving chemotherapy. |
- | Chemotherapy completion date | 561215 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Chemotherapy cycles administered | 561248 | Number
[3]
| 997 | Not applicable-no chemotherapy was administered | 998 | Unknown whether chemotherapy was administered | 999 | Chemotherapy was administered but the number of cycles was not stated/inadequately described |
| |
- | Chemotherapy start date | 561273 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Systemic therapy agent or protocol, eviQ | 561278 | String
[6]
| NNNNNN The eviQ protocol identifier for the systemic therapy agent protocol. | Conditional obligation: Conditional on the administration of systemic therapy agents according to a prespecified regimen or protocol, and on the availability of the protocol number on the eviQ website. |
- | Systemic therapy agent or protocol | 561301 | String
[150]
| X[X(149)] A combination of alphanumeric characters. | |
- | Hormone therapy for cancer cluster | 561324 |
|
| Conditional obligation: Conditional on patient receiving hormone therapy. |
- | Hormone therapy completion date | 561329 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Hormone therapy start date | 561335 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Systemic therapy agent or protocol, eviQ | 561278 | String
[6]
| NNNNNN The eviQ protocol identifier for the systemic therapy agent protocol. | Conditional obligation: Conditional on the administration of systemic therapy agents according to a prespecified regimen or protocol, and on the availability of the protocol number on the eviQ website. |
- | Systemic therapy agent or protocol | 561301 | String
[150]
| X[X(149)] A combination of alphanumeric characters. | |
- | Immunotherapy for cancer cluster | 561356 |
|
| Conditional obligation: Conditional on patient receiving immunotherapy. |
- | Immunotherapy completion date | 561360 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Immunotherapy start date | 561366 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Systemic therapy agent or protocol, eviQ | 561278 | String
[6]
| NNNNNN The eviQ protocol identifier for the systemic therapy agent protocol. | Conditional obligation: Conditional on the administration of systemic therapy agents according to a prespecified regimen or protocol, and on the availability of the protocol number on the eviQ website. |
- | Systemic therapy agent or protocol | 561301 | String
[150]
| X[X(149)] A combination of alphanumeric characters. | |
- | Radiotherapy for cancer cluster | 561380 |
|
| Conditional obligation: Conditional on the patient receiving radiotherapy. |
- | Radiation dose administered | 561384 | Number
[5]
| 999.97 | Not applicable-radiotherapy was not administered | 999.98 | Unknown whether radiotherapy was administered | 999.99 | Radiotherapy was administered but the dose is not stated/inadequately described |
| |
- | Radiotherapy completion date | 561389 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Radiotherapy fractions administered | 561464 | Number
[2]
| 97 | Not applicable-no radiotherapy was administered | 98 | Unknown whether radiotherapy was administered | 99 | Radiotherapy administered but the number of fractions not stated/inadequately described |
| |
- | Radiotherapy start date—cancer treatment | 561469 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Radiotherapy target site | 561476 | Number
[2]
| 1 | Primary site only | 2 | Regional nodes only | 3 | Distant metastases only | 4 | Primary site and regional nodes | 5 | Primary site and distant metastases | 6 | Primary site, regional nodes and distant metastases | 7 | Regional nodes and distant metastases | 97 | Not applicable-radiotherapy was not administered | 98 | Unknown whether radiotherapy was administered | 99 | Radiotherapy was administered but the site not stated/inadequately described |
| |
- | Radiotherapy treatment type | 561521 | Number
[2]
| 1 | External beam radiotherapy only | 2 | Brachytherapy only | 3 | Unsealed radioisotopes only | 4 | External beam radiotherapy and brachytherapy | 5 | External beam radiotherapy and unsealed radioisotopes | 6 | Brachytherapy and unsealed radioisotopes | 7 | External beam radiotherapy, brachytherapy and unsealed radioisotopes | 97 | Not applicable-radiotherapy was not administered | 98 | Unknown whether radiotherapy was administered | 99 | Radiotherapy was administered but the treatment type not stated/inadequately described |
| |
- | Surgery for cancer cluster | 561539 |
|
| Conditional obligation: Conditional on the patient receiving cancer-directed surgery. |
- | Surgery target site | 561567 | String
[5]
| ANN.N
The ICD-O (3rd edition) topography code set representing the site of the tumour. | |
- | Surgical procedure date | 561574 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Surgical procedure for cancer | 562816 | Number
[7]
| NNNNN-NN The Australian Classification of Health Intervention (8th edition) code set representing procedures. | |
- | Systemic therapy procedure for cancer cluster | 561601 |
|
| Conditional obligation: Conditional on the patient receiving a systemic therapy procedure. |
- | Systemic therapy procedure date | 561606 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Systemic therapy procedure | 561612 | Number
[2]
| 1 | A bone marrow transplant procedure was administered but the type was not specified | 2 | Bone marrow transplant—autologous only | 3 | Bone marrow transplant—allogeneic only | 4 | Stem cell harvest and infusion only | 5 | Endocrine surgery and/or endocrine radiation therapy only | 6 | Combination of endocrine surgery and/or radiation with a transplant procedure | 96 | Other systemic therapy procedure | 97 | Not applicable-no systemic therapy procedures were administered | 98 | Unknown whether systemic therapy procedures were administered | 99 | Systemic therapy procedures were administered but were not stated/inadequately described |
| |
- | Cancer staging scheme source edition number | 393398 | Number
[2]
| 97 | Not applicable | 98 | Unknown | 99 | Not stated/inadequately described |
| |
- | Staging scheme source | 393364 | Number
[2]
| 1 | TNM Classification of Malignant Tumours (UICC) | 2 | Durie & Salmon for multiple myeloma staging | 3 | French-American-British (FAB) for leukaemia classification | 4 | Australian Clinico-Pathological Staging (ACPS) System for colorectal cancer | 5 | International Federation of Gynecologists & Obstetricians (FIGO) for gynaecological cancers | 6 | Dukes/Modified Dukes for colorectal cancer | 7 | Ann Arbor staging system for lymphomas | 8 | Binet Staging Classification for chronic lymphocytic leukaemia | 9 | Rai staging system for chronic lymphocytic leukaemia | 10 | Chronic Myeloid Leukaemia (CML) staging system | 11 | International Staging System (ISS) for myeloma | 12 | American Joint Committee on Cancer (AJCC) Cancer Staging Manual | 96 | Other reference | 97 | Not applicable | 98 | Unknown | 99 | Not stated/inadequately described |
| |
- | Staging basis of cancer | 422604 | String
[1]
| | |
- | Cancer treatment type | 561618 | Number
[2]
| 1 | Surgery only | 2 | Radiotherapy only | 3 | Systemic agent therapy only | 4 | Surgery and radiotherapy | 5 | Surgery and systemic agent therapy | 6 | Radiotherapy and systemic agent therapy | 7 | Surgery, radiotherapy and systemic agent therapy | 97 | Not applicable—treatment was not administered | 98 | Unknown whether treatment was administered | 99 | Treatment was administered but the type was not stated/inadequately described |
| |
- | Other cancer treatment description | 561623 | String
[150]
| X[X(149)] The cancer-directed treatment administered to the patient that cannot be defined as surgery, radiotherapy or systemic therapy. | Conditional obligation: Conditional on the patient having treatment that cannot be defined as surgery, radiotherapy or systemic therapy according to the definitions of those data items in this data set specification. |
- | Outcome of treatment | 561665 | Number
[2]
| 1.0 | Complete response/no evidence of disease | 2.1 | Partial response | 2.2 | Stable or static disease | 2.3 | Progressive disease | 7.0 | Not assessed or unable to be assessed | 8.0 | Unknown | 9.0 | Not stated/inadequately described |
| |
- | Date accuracy indicator | 294429 | String
[3]
| AAA | Day, month and year are accurate | AAE | Day and month are accurate, year is estimated | AAU | Day and month are accurate, year is unknown | AEA | Day is accurate, month is estimated, year is accurate | AEE | Day is accurate, month and year are estimated | AEU | Day is accurate, month is estimated, year is unknown | AUA | Day is accurate, month is unknown, year is accurate | AUE | Day is accurate, month is unknown, year is estimated | AUU | Day is accurate, month and year are unknown | EAA | Day is estimated, month and year are accurate | EAE | Day is estimated, month is accurate, year is estimated | EAU | Day is estimated, month is accurate, year is unknown | EEA | Day and month are estimated, year is accurate | EEE | Day, month and year are estimated | EEU | Day and month are estimated, year is unknown | EUA | Day is estimated, month is unknown, year is accurate | EUE | Day is estimated, month is unknown, year is estimated | EUU | Day is estimated, month and year are unknown | UAA | Day is unknown, month and year are accurate | UAE | Day is unknown, month is accurate, year is estimated | UAU | Day is unknown, month is accurate, year is unknown | UEA | Day is unknown, month is estimated, year is accurate | UEE | Day is unknown, month and year are estimated | UEU | Day is unknown, month is estimated, year is unknown | UUA | Day and month are unknown, year is accurate | UUE | Day and month are unknown, year is estimated | UUU | Day, month and year are unknown |
| |
- | Establishment number | 269975 | Number
[5]
| NNNNN A combination of numeric characters that identify an entity. | |
- | HPI-O | 426830 | Number
[16]
| N(16) A unique combination of numbers that identifies an individual or organisation where healthcare is provided within Australia. | |
- | Cancer status | 394071 | Number
[1]
| 1 | No evidence of cancer | 2 | Evidence of cancer | 8 | Unknown whether there is evidence of cancer | 9 | Not stated/inadequately described |
| |
- | Date of last contact—cancer patient | 394060 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Date of diagnosis of cancer | 416129 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Date of diagnosis of first recurrence as distant metastasis | 393841 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | Conditional obligation: Conditional on the patient being diagnosed with recurrence involving a distant metastasis. |
- | Date of diagnosis of first recurrence as locoregional cancer | 393837 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | Conditional obligation: Conditional on the patient being diagnosed with recurrence of locoregional cancer. |
- | Address line (person) | 286620 | String
[180]
| X[X(179)] A combination of alphanumeric characters. | |
- | Family name | 286953 | String
[40]
| X[X(39)] A combination of alphanumeric characters. | |
- | Given name(s) | 287035 | String
[40]
| X[X(39)] A combination of alphanumeric characters. | |
- | Cancer staging—M stage code | 403720 | String
[3]
| 997 | Not applicable | 998 | Unknown | 999 | Not stated/inadequately described |
| |
- | Cancer staging—stage grouping other | 393377 | String
[6]
| 999997 | Not applicable | 999998 | Unknown | 999999 | Not stated/inadequately described |
| |
- | Cancer staging—TNM stage grouping code | 403726 | String
[3]
| 997 | Not applicable | 998 | Unknown | 999 | Not stated/inadequately described |
| |
- | Histopathological grade | 422555 | Number
[1]
| 1 | Grade 1: Low grade; well differentiated, differentiated, NOS | 2 | Grade 2: Intermediate grade, moderately differentiated, moderately well differentiated, intermediate differentiation | 3 | Grade 3: High grade, poorly differentiated | 4 | Grade 4: Undifferentiated, anaplastic | 9 | Grade or differentiation not determined, not stated or not applicable |
| |
- | Laterality of primary cancer | 422769 | String
[1]
| R | Right | L | Left | B | Bilateral | N | Not applicable | U | Unknown |
| |
- | Morphology of cancer | 399491 | Number
[5]
| NNNN/N The ICD-O (3rd edition) code set representing the histology and behaviour of cancer tissue. | |
- | Most valid basis of diagnosis of cancer | 422772 | Number
[1]
| 0 | Death certificate only: Information provided is from a death certificate | 1 | Clinical: Diagnosis made before death, but without any of the following (codes 2-7) | 2 | Clinical investigation: All diagnostic techniques, including x-ray, endoscopy, imaging, ultrasound, exploratory surgery (e.g. laparotomy), and autopsy, without a tissue diagnosis | 4 | Specific tumour markers: Including biochemical and/or immunological markers that are specific for a tumour site | 5 | Cytology: Examination of cells from a primary or secondary site, including fluids aspirated by endoscopy or needle; also includes the microscopic examination of peripheral blood and bone marrow aspirates | 6 | Histology of metastasis: Histological examination of tissue from a metastasis, including autopsy specimens | 7 | Histology of a primary tumour: Histological examination of tissue from primary tumour, however obtained, including all cutting techniques and bone marrow biopsies; also includes autopsy specimens of primary tumour | 8 | Histology: either unknown whether of primary or metastatic site, or not otherwise specified | 9 | Unknown. |
| |
- | Most valid basis of diagnosis of recurrence | 394047 | Number
[1]
| 0 | Death certificate only: Information provided is from a death certificate | 1 | Clinical: Diagnosis made before death, but without any of the following (codes 2-7) | 2 | Clinical investigation: All diagnostic techniques, including x-ray, endoscopy, imaging, ultrasound, exploratory surgery (e.g. laparotomy), and autopsy, without a tissue diagnosis | 4 | Specific tumour markers: Including biochemical and/or immunological markers that are specific for a tumour site | 5 | Cytology: Examination of cells from a primary or secondary site, including fluids aspirated by endoscopy or needle; also includes the microscopic examination of peripheral blood and bone marrow aspirates | 6 | Histology of metastasis: Histological examination of tissue from a metastasis, including autopsy specimens | 7 | Histology of a primary tumour: Histological examination of tissue from primary tumour, however obtained, including all cutting techniques and bone marrow biopsies; also includes autopsy specimens of primary tumour | 8 | Histology: either unknown whether of primary or metastatic site, or not otherwise specified | 9 | Unknown. |
| Conditional obligation: Conditional on the return, reappearance or metastasis of cancer of the same histology after a disease-free intermission or remission. |
- | Regional lymph nodes positive | 415959 | Number
[2]
| 99 | Not stated/inadequately described |
| Conditional obligation: Conditional on the regional lymph nodes being excised and examined by a pathologist and demonstrated to be positive for malignancy. |
- | Number of regional lymph nodes examined | 415971 | Number
[2]
| 99 | Not stated/inadequately described |
| Conditional obligation: Conditional on the regional lymph nodes being excised and examined by a pathologist. |
- | Primary site of cancer (ICD-O-3 code) | 396090 | String
[5]
| ANN.N
The ICD-O (3rd edition) topography code set representing the site of the tumour. | |
- | Cancer staging—T stage code | 403564 | String
[4]
| 9997 | Not applicable | 9998 | Unknown | 9999 | Not stated/inadequately described |
| |
- | Region of first recurrence as distant metastasis | 393854 | String
[5]
| ANN.N
The ICD-O (3rd edition) topography code set representing the site of the tumour. | Conditional obligation: Conditional on the patient being diagnosed with recurrence of distant metastasis. |
- | Region of first recurrence as locoregional cancer | 393848 | String
[5]
| ANN.N
The ICD-O (3rd edition) topography code set representing the site of the tumour. | Conditional obligation: Conditional on the patient being diagnosed with recurrence of locoregional cancer. |
- | Cancer staging—N stage code | 403661 | String
[3]
| 997 | Not applicable | 998 | Unknown | 999 | Not stated/inadequately described |
| |
- | Tumour size at diagnosis (solid tumours) | 422642 | String
[3]
| | Conditional obligation: Conditional on the histopathological examination of the tumour, and excludes Phyllodes tumours, sarcomas or lymphomas. |
- | Date of birth | 287007 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | |
- | Date of death | 287305 | Date/Time
[8]
| DDMMYYYY The day of a particular month and year. | Conditional obligation: Recorded when the patient has died.DSS specific information: This field must be greater than or equal to Date of diagnosis of primary cancer. |
- | Medicare card number | 270101 | Number
[11]
| N(11) A combination of numeric characters that uniquely identify a Medicare customer. | |
- | Indigenous status | 291036 | Number
[1]
| 1 | Aboriginal but not Torres Strait Islander origin | 2 | Torres Strait Islander but not Aboriginal origin | 3 | Both Aboriginal and Torres Strait Islander origin | 4 | Neither Aboriginal nor Torres Strait Islander origin | 9 | Not stated/inadequately described |
| |
- | Person identifier | 290046 | String
[20]
| XXXXXX[X(14)] A logical combination of valid alphanumeric characters that identify an entity. | |
- | Sex | 287316 | Number
[1]
| 1 | Male | 2 | Female | 3 | Intersex or indeterminate | 9 | Not stated/inadequately described |
| |
- | Underlying cause of death | 307931 | String
[6]
| ANN-ANN The ICD10 code set representing the disease or injury which initiated the train of morbid events leading directly to death or the circumstances of the accident or violence which produced the fatal injury (WHO 2004) | Conditional obligation: Recorded when the patient has died. |